Home | Welcome to Contract Pharma   
Last Updated Sunday, December 21 2014

Print

Topics - Manufacturing


Refine by Date:
From: To:
Published December 16, 2014
To focus on commercial manufacturing for solid dosage products Read More »
Published December 16, 2014
CMC will provide process development and GMP manufacture of OS2966 Read More »
Published December 15, 2014
Broadens access to key biotech hubs Read More »
Published December 15, 2014
Includes Czech production facility and assets for H5N1, H1N1 and seasonal flu vaccines Read More »
Published December 12, 2014
Ravalli to oversee NJ ops Read More »
Published December 11, 2014
Offers new manufacturing options and additional filling capacity Read More »
Published December 10, 2014
Werum's PAS-X V3.1.5 covers areas of API manufacturing and product warehouse Read More »
Published December 4, 2014
Reaffirms commitment to NJ Read More »
Published December 4, 2014
To impact employees and Strängnäs ops Read More »
Published December 4, 2014
Will support the development and reprofiling of zolpidem using Catalent’s OSDrC OptiDose Read More »
Published December 4, 2014
Expands sterile filling segment Read More »
Published December 2, 2014
Catalent to provide cell line engineering, process development, and manufacturing Read More »
Published December 1, 2014
Expands development capacity and technical capabilities Read More »
Published November 21, 2014
Increased production capacity to support maturing biologics pipeline Read More »
Published November 21, 2014
Expands capacity for immunology and oncology pipelines Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On